On June 2, 2022, William Sellers, M.D. informed 2seventy bio, Inc. of his intention to resign as a member of the Company's Board of Directors, effective June 3, 2022. Dr. Sellers's decision to resign from the Board did not result from any disagreement with the Company on any matter relating to its operations, policies, or practices. Following his resignation from the Board, Dr. Sellers will begin serving as a scientific and technical consultant to the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.22 USD | -3.21% | -6.43% | -1.17% |
08/05 | Earnings Flash (TSVT) 2SEVENTY BIO Reports Q1 Revenue $12.4M, vs. Street Est of $14.1M | MT |
08/05 | Transcript : 2seventy bio, Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.17% | 224M | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- TSVT Stock
- News 2seventy bio, Inc.
- 2Seventy Bio, Inc. Announces Resignation of William Sellers to Its Board of Directors